Budget Amount *help |
¥137,930,000 (Direct Cost: ¥106,100,000、Indirect Cost: ¥31,830,000)
Fiscal Year 2021: ¥27,560,000 (Direct Cost: ¥21,200,000、Indirect Cost: ¥6,360,000)
Fiscal Year 2020: ¥27,560,000 (Direct Cost: ¥21,200,000、Indirect Cost: ¥6,360,000)
Fiscal Year 2019: ¥27,560,000 (Direct Cost: ¥21,200,000、Indirect Cost: ¥6,360,000)
Fiscal Year 2018: ¥27,560,000 (Direct Cost: ¥21,200,000、Indirect Cost: ¥6,360,000)
Fiscal Year 2017: ¥27,690,000 (Direct Cost: ¥21,300,000、Indirect Cost: ¥6,390,000)
|
Outline of Final Research Achievements |
We addressed the concept of "sex spectrum" in humans. Our notable achievements include (i) discovery of several novel genetic abnormalities leading to disorders of sex development, pubertal disorders, and spermatogenic failure; (ii) elucidation of the physiological and pathological roles of novel human androgens (11-oxygenated C19 steroids); (iii) clarification of the timing of X chromosome inactivation and aneuploidy rescue in early embryos. (iv) understanding the effects of intrauterine malnutrition on sex differentiation and spermatogenesis; and (v) elucidating sex hormone metabolism in healthy prepubertal children and in the placenta.
|